Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-05-05
1997-10-14
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 47, 536 2623, 536 2626, 536 267, 536 276, A61K 3170
Patent
active
056772904
ABSTRACT:
A method of inducing anesthesia, sedation, analgesia, hypothermia, and reduced stress by administering an effective amount of an adenosine compound to a mammal. It also provides a method for preserving donor organs in vivo by contacting them with an adenosine compound, as well as a method for preparing organ recipients for transplant.
REFERENCES:
patent: 4590180 (1986-05-01), Irmscher et al.
patent: 4605644 (1986-08-01), Foker
patent: 4673563 (1987-06-01), Berne et al.
patent: 4755594 (1988-07-01), Bridges et al.
patent: 4880783 (1989-11-01), Mentzer, Jr. et al.
patent: 4880918 (1989-11-01), Rapaport
patent: 5049372 (1991-09-01), Rapaport
patent: 5104859 (1992-04-01), Sollevi
Fukunaga et al. (I), Anesthesiology, 57, A65 (1982).
Fukunaga et al. (II), Anesthesiology, 61, 273-278 (1982).
Dunwiddle et al., J. Pharm. and Expert Therapeutics, 220, 70-76 (1982).
Seitz et al., Anesthesiology, 68, A263 (1989).
Moser et al., "Turnover of Adenosine in Plasma of Human and Dog Blood," Am. J. Physiology 256 (Cell Physiology 25), C799-C806 (1989).
Lam et al., "Cerebral Blood Flow Autoregulation During Adenosine-Induced Hypotension in Dogs," Anesthesia and Analgesia, 70, S223 (1990).
Fukunaga et al. (I), "ATP Induced Hypotensive Anesthesia During Surgery," Anesthesiology, 57, A65 (1982).
Fukunaga et al. (II), "Hypotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside," Anesthesiology, 61(3), 273-278 (1982).
Dunwiddie et al., "Sedative and Anticonvulsive Effects of Adenosine Analogs in Mouse and Rat," J. Pharm. and Expert Therapeutics, 220, 70-76 (1982).
Seitz et al., "Adenosine Reduces Halothane MAC in Dogs," Anesthesiology, 68, A263 (1989).
Homeister et al., "Combined Adenosine and Lidocaine Administration Limits Myocardial Reperfusion Injury," Circulation, 82(2), 595-608 (1990).
Gomma, "Characteristics of Analgesia Induced by Adenosine Triphosphate," Pharmacology and Toxicology, 61, 199-202 (1987).
Drury et al., "The Physiological Activity of Adenine Compounds with Especial Reference to Their Action Upon the Mammalian Heart," J. Physiology (Cambridge, England), 68, 213-237 (1929).
Birch et al., "L-Phenylisopropyladenosine (L-PIA) Diminishes Halothane Anesthetic Requirements and Decreases Noradrenergic Neurotransmission in Rats," Life Sciences, 42, 1355-1360 (1988).
Vapaatalo et al., "Stereospecificity in Some Central and Circulatory Effects of Phenylisopropyladenosine (PIA)", Arzneim. Forsch (Drug Res.), 25(3), 407-410 (1975).
Phillis et al. (I), "Roles of Adenosine and Adenine Nucleotides in the Central Nervous System," in Physiology and Pharmacology of Adenosine Derivatives, Daly et al. eds., Raven Press, New York, 1983, pp. 219-235.
Phillis et al. (II), "Evidence for an A.sub.2 -like Receptor on Cerebral Cortical Neurons," J. Pharm. Pharmacol. 34, 453-454 (1982).
Nunn et al., "Introduction," in General Anesthesia, 5th Ed., Nunn et al. eds., Butterworth, London, 1989, pp. 1-6.
Ohisalo et al., "Regulatory Functions of Adeonsine," Medical Biology, 65, 181-191 (1987).
Williams, "Tissue and Species Differences in Adenosine Receptors and Their Possible Relevance to Drug Development," in Adenosine: Receptors and Modulation of Cell Function, Stefanovich et al. (eds.), IRL Press Ltd., Oxford, UK, 1985, pp. 73-84.
Stoelting et al. (eds.), Principles of Anesthesia, 2nd Ed., Churchill Livingstone, New York, NY, 1989, pp. 115-119.
Katzung (ed.) Basic & Clinical Pharmacology, Ch 24, Appleton & Lange, Norwalk, Connecticut, 1995, pp. 381-394.
Seitz et al., "Adenosine Decreases the Minimum Aveolar Concentration of Halothane in Dogs," Anesthesiology, 73, 990-994 (1990).
Orwall et al., "Clinical Experience with Adenosine for Controlled Hypotension During Cerebral Aneurysm Surgery", Anesthesiology and Analgesia, 66, 229-234 (1987).
Williams, "Purine Receptors in Mammalian Tissues: Pharmacology and Functional Significance," Ann. Rev. Pharmacology & Toxicology, 27, 315-345 (1987); see particularly pp. 316, 328-329 and 335 refer to hypnotic effects.
Haulica et al., "Preliinary Data on the Possibel Hypnogenic Role of Adenosine," J. Neurochem., 21, 10-19-1920 (1973).
Birch et al., "L-phenylisopropyladenosine (L-PIA) Diminishes Halothane Anesthetioc Requirements and Decreases Neurotransmission in Rats," Life Science, 42(14), 1355-1360 (1988); p. 1355, second paragraph, lines 5-7.
Conradson et al., "Cardiovascular Effects of Infused Adenosine: Potentiation by Dipyridamole," 129, 387-391 (1987). of Anesthetic Potency," Anesthesiology, 26, 756-763 (1965).
Snyder, "Adenosine as Neuromodulator," Ann. Rev. Neuroscience, 8, 103-124 (1985); see pp. 108 & 119, second paragraphs.
Bloor et al., "Reduction of Halothane Anesthetic Requirement by Clonidine, an Alpha-Aderenegic Agonist," Anesthesia and Analgesia, 61, 741-745 (1982).
Maze et al., "Anesthetic and Hemodynamic Effects of Alpha.sub.2 -Adrenergic Agoinst, Azepexole, in Isoflurane-Anesthetized Dogs," Anesthesiology, 68(5), 689-694 (1988).
Segal et al., "Dexmedetomindine Diminishes Halothane Anesthetic Requirements in Rats Through a Post Synaptic Alpha.sub.2 Andrenergic Receptor," Anesthesiology 68(6), 818-823 (1988); see particularly col. 2 of p. 818, last paragraph.
Tanifuji et al., "Effect of Arterial Hypotension on Anesthetic Requirements in Dogs," British J. Anesthesiology, 48(10), 947-951 (1976).
Dunwiddie, "The Physiological Role of Adenosine in the Central Nervous System," International Reviews in Neurobiology, 27, 63-139 (1985); see particularly pp. 95-99, 121 and 126-128.
Feldberg et al., "Injection of Drugs into the Left Ventricle of the Cat," J. Physiology London, 123, 148-167 (1954).
Radulovacki et al., "Hypnotic Effects of Deoxycoformycin in Rats," Brain Research, 27, 271, 392-395 (1983).
Jonzon et al., "Modulation of Neurotransmission by Purine Nucleosides and Nucleotides," Life Science, 1984 1971-1979.
Galloway et al., "Clonidine Prevents Methylxanthanine Stimulation of NE Metabolism in Rats," J. Neurochemistry, 40, 246-251 (1983).
T. Andor, et al.; Acta Anesthesiologica Scandinavica 37 (1993) "Effects of adenosine triphosphate (ATP) on somatosensory evoked potentials in humans anesthetized with isoflurane and nitrous oxide"; pp. 500-593.
Jean-Luc Daval, et al.; Life Sciences, vol. 49, pp. 1435, 1991; Minireview; "Physiological and Pharmacological Properties of Adenosine: Therapeutic Implications".
D.F. Dedrick, M.D., et al.; ASA Abstracts; Anethesiology vol. 57, No. 3, Sep. 1982; p. A66; "Does ATP-Induced Hypotension Cause Potentially Serious Metabolic Complications?".
Fukayama, et al.; Anesth Prog 36:169-177; 1989; "Effects of Hypotensive Anesthesia on Endocrine Systems in Oral Surgery".
Loeser, et al.; Pain, 25 (1986) pp. 149-164; Clinical Section, Review Article; "Herpes Zoster and Postherpetic Neuralgia".
Sklar, et al.; Herpes Zoster; Preliminary Communication; JAMA, Mar. 8, 1985; vol. 253, No. 10; pp. 1427-1430; "The Treatment and Prevention of Neuralgia With Adenosine Monophosphate".
A. Sollevi; Acta Anasthesiol Scand 1992; 36: 595-599; Case report; "Adenosine infusion during isoflurane-nitrous oxide anaesthesia: indications of perioperative analgesic effect".
Zall, et al.; Anesth Analg; 1990; 71: 631-636; "Controlled Hypotension with Adensoine or Sodium Nitroprusside During Cerebral Aneurysm Surgery: Effects on Renal Hemodynamics, Excretory Function, and Renin Release".
Michael Williams; Annals New York Academy of Sciences; 1990; pp. 93-94; "Purine Nucleosides and Nucleotides as Central Nervous System Modulators".
Benumof JL, et al: ATP inhibits pulmonary vasoconstriction. Anesthesiology 57:A474, 1982.
Bloor BC, et al: Coronary sinus blood flow during hypotension induced by sodium nitroprusside or adenosine triphosphate infusion. Anesthesiology 57:A51, 1982.
Bloor BC, et al: Myocardial hemodynamics during induced hypotension: A comparsion between sodium nitroprusside and adenosine triphosphate. Anesthesiology 63:517-525, 1985.
Daval JL, et al: Physiological and pharmacological properties of adenosine: Therapeutic implications. Minireview. Life Sciences 49:1435-1453, 1991.
Dubyak GR, et al eds. Biological Act
Crane L. Eric
Kunz Gary L.
LandOfFree
Therapeutic use of adenosine compounds as surgical anesthetics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of adenosine compounds as surgical anesthetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of adenosine compounds as surgical anesthetics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555397